MREO
Mereo BioPharma Group PLC ADR
NASDAQ: MREO · HEALTHCARE · BIOTECHNOLOGY
$0.27
-2.89% today
Updated 2026-04-30
Market cap
$44.72M
P/E ratio
—
P/S ratio
89.45x
EPS (TTM)
$-0.25
Dividend yield
—
52W range
$0 – $3
Volume
1.6M
Mereo BioPharma Group PLC ADR (MREO) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $-3.29M | $0.00 | $-122000.00 | $393000.00 | $49.21M | $1.51M | $10.00M | $0.00 | $500000.00 |
| Revenue growth (YoY) | — | — | — | +100.0% | — | +422.1% | +12422.4% | -96.9% | +563.6% | -100.0% | — |
| Cost of revenue | $0.00 | $24.56M | $34.61M | $22.70M | $2.01M | $2.05M | $24.17M | $-257442.00 | $2.57M | $1.09M | $133000.00 |
| Gross profit | $0.00 | $-24.56M | $-37.89M | $-22.70M | $-2.01M | $-2.05M | $25.04M | $257442.00 | $7.43M | $-1.09M | $367000.00 |
| Gross margin | — | — | 1153.4% | — | 1649.0% | -521.8% | 50.9% | 17.1% | 74.3% | — | 73.4% |
| R&D | $214.40M | $24.56M | $34.61M | $22.70M | $30.12M | $20.96M | $31.80M | $30.75M | $17.42M | $20.93M | $17.77M |
| SG&A | $7.67M | $11.62M | $10.70M | $12.50M | $15.91M | $21.22M | $21.50M | $19.54M | $18.42M | $26.43M | $23.01M |
| Operating income | $-13.16M | $-36.18M | $-45.30M | $-35.21M | $-50.41M | $-48.18M | $-28.26M | $-53.67M | $-28.42M | $-47.36M | $-40.50M |
| Operating margin | — | — | 1379.0% | — | 41322.4% | -12258.7% | -57.4% | -3561.2% | -284.2% | — | -8100.3% |
| EBITDA | — | $-38.41M | $-44.44M | $-34.86M | $-44.57M | $-203.41M | $25.49M | $-39.98M | $-26.06M | $-40.80M | $-39.35M |
| EBITDA margin | — | — | 1352.7% | — | 36531.1% | -51759.2% | 51.8% | -2652.9% | -260.6% | — | -7869.9% |
| EBIT | $-518.24M | $-38.44M | $-44.48M | $-34.90M | $-46.58M | $-205.46M | $24.62M | $-40.87M | $-27.12M | $-41.88M | $-40.50M |
| Interest expense | $0.00 | $179765.00 | $1.09M | $2.36M | $3.50M | $6.38M | $5.22M | $3.36M | $2.88M | $1.37M | $255595.00 |
| Income tax | $-1.14M | $-5.33M | $-8.15M | $-5.28M | $-8.00M | $-3.62M | $2.05M | $-2.34M | $-532000.00 | $18200.00 | — |
| Effective tax rate | 8.5% | 15.8% | 17.4% | 14.1% | 15.3% | 1.7% | 10.6% | 5.3% | 1.8% | -0.0% | 0.0% |
| Net income | $-12.19M | $-28.39M | $-38.80M | $-32.03M | $-44.45M | $-209.83M | $17.17M | $-42.12M | $-29.47M | $-43.25M | $-41.88M |
| Net income growth (YoY) | — | -132.9% | -36.7% | +17.4% | -38.8% | -372.0% | +108.2% | -345.3% | +30.0% | -46.8% | +3.2% |
| Profit margin | — | — | 1181.0% | — | 36435.9% | -53391.6% | 34.9% | -2795.1% | -294.7% | — | -8375.6% |